Spatial Concept
FDA Approves New Oral Alzheimer’s Therapy, Expands Label for Grifols SCIg Therapy
FDA, Alzheimer’s disease, Grifols, XEMBIFY, immunoglobulin, subcutaneous, immunodeficiency, plasma-derived therapeutics
Bluebird Bio’s Fertility Support Program for Gene Therapies Rejected by HHS Inspector General
Bluebird Bio, Gene Therapy, Fertility Support, HHS Inspector General, Zynteglo, Skysona, Anti-Kickback Rules
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
Midline (qualifier value), Wages, Pharma, Worker
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
2023, Midline (qualifier value), Gilead, Wages, Average, Highest
Compensation Trends in the Pharmaceutical and Biotech Industry: 2023 Insights
pharmaceutical industry, biotech companies, median salary, employee pay, compensation trends, 2023
Novo Nordisk Acquires 2seventy’s Gene Editing Technology and Haemophilia Candidate for $40 Million
Novo Nordisk, 2seventy, gene editing, haemophilia, MegaTAL, in vivo gene editing technology
Exsilio Emerges from Stealth with $82 Million to Revolutionize Gene Therapy
Exsilio Therapeutics, Gene Therapy, Novel Approach, mRNA, Lipid Nanoparticle Delivery, Biotech Company, Genetic Medicine
Navigating the Complexities of Adding Rare Disease Products to Your Company’s Portfolio
Rare disease products, biopharmaceutical development, commercialization, market access, patient identification, payer contract strategy, value-based contracting, regulatory incentives, emerging technology.
Emergent Biosolutions Sells Baltimore Facility for $30 Million
Emergent Biosolutions, Baltimore facility, sale, Bora, $30 million